Skip to main content
. 2018 Nov 13;10(4):228. doi: 10.3390/pharmaceutics10040228

Figure 10.

Figure 10

Intracellular GSH content after breast cancer cell exposure to MWCNTs (1, 2 µg/mL) and CDDP (0.63, 1.26 µg/mL) for 24 h and 48 h. The results are calculated as the mean ± SD of 3 replicates and represented relative to control. * p < 0.05, ** p < 0.01 vs. control.